Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03564288
Title Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Oscotec Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.